Immunogenicity of Therapeutic Proteins
Suzanne Hermeling, Daan J.A. Crommelin, Huub Schellekens, Wim Jiskoot
Abstract
Suzanne Hermeling, Daan J.A. Crommelin, Huub Schellekens, Wim Jiskoot
Abstract
Abstract The introduction of recombinant DNA techniques has made possible to produce proteins on a large scale. These protein therapeutics are potentially immunogenic, inducing antibodies in patients after a certain period of treatment. This article gives an overview of the current knowledge about the immunogenicity of therapeutic proteins.
OpenAlex reports 38 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract The introduction of recombinant DNA techniques has made possible to produce proteins on a large scale. These protein therapeutics are potentially immunogenic, inducing antibodies in patients after a certain period of treatment. This article gives an overview of the current knowledge about the immunogenicity of therapeutic proteins.
Key concepts: Immunogenicity, Human proteins, Computational biology, Recombinant DNA, Antibody, Biology, Immunology, Medicine